RX SUZUKA
DEAD

Serial Number

85235852

Owner

Randox Laboratories Ltd

Attorney

Richard J. Groos

Filing Date

Feb 7, 2011

Add to watchlist:

No watchlists yet
View on USPTO

RX SUZUKA Trademark

Serial Number: 85235852 • Registration: 4274054

RX SUZUKA is a trademark filed by Randox Laboratories Ltd on February 7, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Randox Laboratories Ltd (13 trademarks)

Crumlin, Co. Antrim
Northern Ireland, BT29 4QY , GB

Entity Type: 16

Trademark Details

Filing Date

February 7, 2011

Registration Date

January 15, 2013

Published for Opposition

October 30, 2012

Cancellation Date

August 16, 2019

Goods & Services

Computer software for scheduling, programming, analysing and reporting on diagnostic tests in the field of biomarkers; computer software for automatic calibration, barcode scanning, reagent information management, reaction process monitoring and cross-contamination prevention in the field of biomarkers; computer software for patient information memory and association input, report auditing, printing and publishing diagnostic test results and statistics in the field of biomarkers; detectors for chemical compounds and reagents in the field of biomarkers; diagnostic apparatus and instruments for the testing of clinical chemistry, toxicology, food and wine, not for medical purposes; diagnostic testing apparatus and instruments for use in immunoassay procedures, not for medical purposes; diagnostic imaging apparatus for the study of chemical compounds and structures other than for medical use; clinical laboratory analytical instruments, namely, clinical chemistry or immunoassay analysers, other than for medical use, all of the foregoing not having to do with the design or development of drugs

Antitoxic sera and antisera for diagnostic purposes; diagnostic preparations for medical and veterinary use, namely, biomarkers; diagnostic preparations for sale in kit form for medical and veterinary use related to biomarkers; diagnostic scanning agents, namely, biomarkers for medical and veterinary use; clinical diagnostic preparations for medical and veterinary use in the field of biomarkers; diagnostic testing preparations for medical and veterinary use in the field of biomarkers; reagents for use in diagnostic tests for medical and veterinary purposes in the field of biomarkers; diagnostic reagents for use with analyzers for medical and veterinary purposes in the field of biomarkers, all of the foregoing not having to do with the design or development of drugs

Chemicals in the field of biomarker diagnostics used in industry, science, photography, agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical reagents for non-medical purposes, namely, biomarkers; enzymes and raw proteins for scientific and research purposes, namely, biomarkers; diagnostic preparations for scientific purposes; diagnostic preparations, namely, biomarkers for analysis of food products and water and all the aforesaid for sale in kit form; clinical diagnostics preparations for clinical or medical laboratory use in the field of biomarker diagnostics; diagnostic scanning agents for scientific and research use, namely, biomarkers; diagnostic testing material, namely, testing of biochemical markers for scientific and research use, all of the foregoing not having to do with the design or development of drugs

Medical apparatus and instruments for use in biomarker diagnostics; diagnostic apparatus and instruments for medical use, namely, biomarkers for detecting and analysing infectious and non-infectious diseases, organ function in humans and animals, therapeutic drugs and drugs of abuse, proteins, acids and antioxidants; clinical chemistry analyzers for disease, toxicology and bodily function analysis for medical and veterinary use in the field of biomarker diagnostics; diagnostic testing apparatus and instruments for use in immunoassay procedures; clinical laboratory analytical instruments for medical and veterinary use, namely, apparatus for clinical diagnosis in the field of biomarkers, all of the foregoing not having to do with the design or development of drugs

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 16, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 15, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 15, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 30, 2012 NPUB
PUBLISHED FOR OPPOSITION
Oct 30, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 10, 2012 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 2, 2012 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 21, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 15, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 15, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 15, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 15, 2012 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2012 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2011 CRFA
ASSIGNED TO LIE
Nov 28, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2011 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 18, 2011 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2011 GNRN
NON-FINAL ACTION E-MAILED
May 9, 2011 GNRT
NON-FINAL ACTION WRITTEN
May 9, 2011 CNRT
ASSIGNED TO EXAMINER
May 6, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2011 NWOS
NEW APPLICATION ENTERED
Feb 10, 2011 NWAP